An international, multicenter phase II trial of bortezomib in patients with hepatocellular carcinoma von Kim, George P., Mahoney, Michelle R., Szydlo, Daniel, Mok, Tony S. K., Marshke, Robert, Holen, Kyle, Picus, Joel, Boyer, Michael, Pitot, Henry C., Rubin, Joseph, Philip, Philip A., Nowak, Anna, Wright, John J., Erlichman, Charles

Volltext